Regulatory peptides as a source of new drugs — the clinical prospects for analogues of TRH which are resistant to metabolic degradation-Reference-Cited by-同舟云学术

Regulatory peptides as a source of new drugs — the clinical prospects for analogues of TRH which are resistant to metabolic degradation

Published:1982-11 Issue:3 Volume:4 Page:389-408
ISSN:0165-0173
Container-title:Brain Research Reviews
language:en
Short-container-title:Brain Research Reviews

Author:

Metcalf Geoffrey

Publisher

Elsevier BV

Subject

Neurology (clinical),General Neuroscience

Reference91 articles.

1. Changes in brain catecholamines and spontaneous locomotor activity in response to thyrotropin releasing hormone;Agarwal;Res. Commun. chem. Pathol. Pharmacol.,1976

2. Clinical side effects of TRH;Almqvist;Front. Hormone Res.,1972

3. Metabolism and excretion of exogenous thyrotropin releasing hormone in humans;Bassiri;J. clin. Invest.,1973

4. EEG and blood pressure effects of TRH in rabbits;Beale;Neuropharmacology,1977

5. Anatogues of thyrotropin releasing hormone (TRH) stimulate in vitro release of endogenous dopamine from rat brain regions;Bennett;Brit. J. Pharmacol,1981

Cited by 174 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The growing complexity of the control of the hypothalamic pituitary thyroid axis and brown adipose tissue by leptin;Vitamins and Hormones;2024

2. Thyrotropin-releasing hormone analog as a stable upper airway-preferring respiratory stimulant with arousal properties;Journal of Applied Physiology;2022-11-01

3. Differential activating effects of thyrotropin-releasing hormone and its analog taltirelin on motor output to the tongue musculature in vivo;Sleep;2020-03-28

4. Nanotechnology for pulmonary and nasal drug delivery;Nanoengineered Biomaterials for Advanced Drug Delivery;2020

5. Dispersible hydrolytically sensitive nanoparticles for nasal delivery of thyrotropin releasing hormone (TRH);Journal of Controlled Release;2019-02